Xu Y - Search Results

1

[Different influence of Her-2 expression on the prognosis in node-positive and node-negative breast cancer].

Wang Y, Yao L, Liu YQ, Xu Y, Ou YT, Li JF, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT. Wang Y, et al. Among authors: xu y. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):511-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029694 Chinese.

2

Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.

Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y. Xu Y, et al. Breast Cancer Res Treat. 2006 May;97(1):49-55. doi: 10.1007/s10549-005-9086-7. Breast Cancer Res Treat. 2006. PMID: 16319978

3

[Prognostic role of apoptosis-related gene Fas-1377 and -670 polymorphisms in breast cancer].

Hu Y, Xu Y, Wang Y, Ouyang T, Li JF, Wang TF, Fan ZQ, Fan T, Lin BY, Geng PL, Xie YT. Hu Y, et al. Among authors: xu y. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):104-7. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538884 Chinese.

4

[Correlation of BRCA1 and APC aberrant methylation with the response to anthracycline-based neoadjuvant chemotherapy in primary breast cancer].

Yuan P, Xu Y, Ouyang T, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT, Li JF. Yuan P, et al. Among authors: xu y. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):282-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615284 Chinese.

5

[Clinicopathologic characteristics and prognosis in young Chinese women with breast cancer].

Liu X, Liu QF, Xu Y, Ouyang T, Li JF, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT. Liu X, et al. Among authors: xu y. Zhonghua Yi Xue Za Zhi. 2011 Jul 12;91(26):1817-20. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093781 Chinese.

6

Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.

Pei R, Xu Y, Wei Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Pei R, et al. Among authors: xu y. Front Med. 2013 Mar;7(1):138-42. doi: 10.1007/s11684-013-0247-5. Epub 2013 Jan 28. Front Med. 2013. PMID: 23358895

7

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.

Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y. Xu Y, et al. Clin Cancer Res. 2005 Oct 15;11(20):7328-33. doi: 10.1158/1078-0432.CCR-05-0507. Clin Cancer Res. 2005. PMID: 16243804

8

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.

Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y. Li H, et al. Among authors: xu y. Acta Oncol. 2006;45(5):597-601. doi: 10.1080/02841860600660803. Acta Oncol. 2006. PMID: 16864175

9

Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status.

Xu Y, Yao L, Zhao A, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Lu Y, Xie Y. Xu Y, et al. Int J Cancer. 2008 Jun 15;122(12):2761-6. doi: 10.1002/ijc.23454. Int J Cancer. 2008. PMID: 18348141

10

BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer.

Chen Y, Zhou J, Xu Y, Li Z, Wen X, Yao L, Xie Y, Deng D. Chen Y, et al. Among authors: xu y. Cancer Sci. 2009 Sep;100(9):1663-7. doi: 10.1111/j.1349-7006.2009.01225.x. Epub 2009 May 18. Cancer Sci. 2009. PMID: 19522853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,493 results

Search Page

Filters